Stocks

Oragenics: It’s even worse than it looks!

by Sentiment Analyst

Oragenics Positive Sentiment Signals An evaluation of the rate of change in sentiment and the intensity of discussion reveals the following pictureDuring the past month, investor sentiment increasingly improved. Therefore, we rate this item as...

Read More

Price explosion at Block (ex Square)!

by Sentiment Analyst

Block (ex Square) - analysts are enthusiastic The consensus for Block, according to analysts who have issued a recommendation in the past 12 months, is as followsOverall, the result is a "Buy", as there are 24 Buc, 4 Hold, 0 Sell ratings. However,...

Read More

Clear signals at Coca-Cola!

by Sentiment Analyst

Coca-Cola leads the way The stock generated a return of 23.8 percent last year. Compared to stocks in the same sector ("consumer staples"), this puts Coca-cola 1.96 percent above the average (21.84 percent). The average annual return for securities...

Read More

S&P Emerging Markets Share: That was obvious …

by Sentiment Analyst

S&P Emerging Markets: The RSI with new signals The Relative Strength Index, abbreviated as RSI, indexes the movements of stock prices within 7 days by relating the upward movements to the number of movements. The standard range is from 0 to 100,...

Read More

Salesforce is back!

by Sentiment Analyst

Analysts take a positive view of Salesforce Out of a total of 35 analyst ratings from the past twelve months for Salesforce stock, 30 are "Buy," 4 are "Hold" and 1 is "Sell." That averages out to a "Buy" rating for the stock. In recent reports,...

Read More

Pfizer: Very bad prospects!

by Sentiment Analyst

Pfizer: Investors are disgruntled The discussions around Pfizer on social media platforms give a clear signal about the assessments and moods around the title. Currently, negative opinions are piling up overall in the comments and opinions in the...

Read More